The Vall d’Hebron Research Institute (VHIR) is a multidisciplinary biomedical research organisation that promotes and develops innovative health research projects at Vall d’Hebron University Hospital (HUVH). It was created in 1994 to enhance the research infrastructure of the hospital, which is one of the leading medical facilities in Catalonia, and one of the largest in Spain with more than 1,300 beds and 7,000 employees. VHIR aims to undertake high quality and competitive research and teaching at an international level in the field of health and life sciences. It is involved in a wide range of research areas spanning basic science and clinical trials, to epidemiological, economic and healthcare studies. More than 1,300 people work at VHIR, out of which over 1,200 do research and around 100 people provide support in research and its transfer to society, whether achieved by projects, technology transfer and innovation, communication, or fundraising. VHIR has been involved in different international health projects. Currently, there are more than 123 ongoing projects funded by international organisations (H2020, FP7, DGSANTE, IMI, NIH and other private foundations), 13 of which are being led by VHIR as coordinator. Regarding migrant health and infectious diseases, the institution coordinated the European Consortium “Benznidazol and triazole REsearch group for Nanomedicine and Innovation on Chagas disease” (BERENICE) from the 7th FP (FP7-HEALTH 2012 GA305937). BERENICE is aimed at obtaining a more effective, better tolerated and cheaper formulation of a drug with trypanocidal activity to cure Chagas disease. Regarding public health and migration, the institution coordinated MyHealth project, a European project con-funded by CHAFEA (PN 738091) with the main objective of improving the healthcare access of vulnerable immigrants and refugees by developing and implementing models based on the knowhow of a European multidisciplinary network. Other projects related to migration and health are: “Raising the immigrant population of the importance of control and prevention of tuberculosis”; “Chagas expert Patient”; “Training for Acting”; “Pretravel health advice for VFR (visiting friends and Relatives) and people involved in pilgrimage trips to Mecca and Medina”; and “Art Wonee: disseminates artistic expressions related to tropical medicine and migratory journeys”.

Back “Partners”